You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 12, 2025

Suppliers and packagers for SENSIPAR


✉ Email this page to a colleague

« Back to Dashboard


SENSIPAR

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Amgen SENSIPAR cinacalcet hydrochloride TABLET;ORAL 021688 NDA Amgen Inc 55513-073-30 30 TABLET, COATED in 1 BOTTLE, PLASTIC (55513-073-30) 2004-04-04
Amgen SENSIPAR cinacalcet hydrochloride TABLET;ORAL 021688 NDA Amgen Inc 55513-074-30 30 TABLET, COATED in 1 BOTTLE, PLASTIC (55513-074-30) 2004-04-04
Amgen SENSIPAR cinacalcet hydrochloride TABLET;ORAL 021688 NDA Amgen Inc 55513-075-30 30 TABLET, COATED in 1 BOTTLE, PLASTIC (55513-075-30) 2004-04-04
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Last updated: August 1, 2025

ppliers for the Pharmaceutical Drug: SENSIPAR

Introduction

SENSIPAR (roluprolide acetate) is a pharmaceutical product primarily indicated for the treatment of prostate cancer, precocious puberty, and other hormone-dependent conditions. As a peptide-based drug, its manufacturing relies heavily on specialized suppliers that provide high-quality active pharmaceutical ingredients (API), excipients, and manufacturing services. This analysis identifies key suppliers integral to the SENSIPAR supply chain, examining their roles, regional presence, and strategic importance for pharmaceutical companies, healthcare providers, and investors.


Active Pharmaceutical Ingredient (API) Suppliers for SENSIPAR

Role of API Suppliers
The core of SENSIPAR production involves sourcing high-purity roluprolide acetate, a peptide hormone analog. This compound is complex to synthesize, necessitating advanced peptide synthesis technologies, rigorous purification, and strict quality controls. Suppliers of this API must comply with Good Manufacturing Practices (GMP), adhere to stringent regulatory standards, and often operate within the frameworks of major global health authorities such as the FDA, EMA, or PMDA.


Major API Suppliers for SENSIPAR

1. Polypeptide Suppliers – Global Leaders

Leading global suppliers of peptide APIs that could be involved in SENSIPAR production include large biopharmaceutical contract manufacturing organizations (CMOs):

  • Bachem
    Bachem offers peptide synthesizing capabilities suited for complex APIs like SENSIPAR. Their facilities across Switzerland, the US, and China support high-volume production with adherence to GMP standards. Bachem’s expertise in peptide synthesis makes it a strategic partner for biologics and peptide-based drugs.

  • Boehringer Ingelheim
    This German pharmaceutical giant operates extensive peptide manufacturing units and supplies custom peptide APIs to clients globally. Their technological edge in peptide synthesis and purification underpins the quality and consistency of their products.

  • Samsung Biologics
    With rapid expansion into peptide manufacturing, Samsung Biologics of South Korea offers integrated services, including API synthesis, purification, filling, and packaging. Their robust capacity positions them as viable API suppliers.

  • WuXi AppTec
    This Chinese contract development and manufacturing organization (CDMO) is a key player in peptide synthesis. WuXi’s global presence and capacity for GMP production services make it a significant API supplier network for peptide drugs like SENSIPAR.

2. Specialized Peptide Synthesis Firms

Niche peptide synthesis companies such as PolyPeptide Laboratories and Genscript are also potential API sources, particularly for smaller batches or research services transitioning to commercial production.


Excipients and Formulation Suppliers

While the API forms the core, excipients influence drug stability, bioavailability, and delivery. Suppliers of reliable excipients for injectables include:

  • Fresenius Kabi
    Provides sterile water, buffers, and stabilizers for peptide injectables. Their focus on sterile, GMP-certified excipients ensures compatibility with SENSIPAR’s formulation requirements.

  • DCC (Danish Collectors & Chemists) and BASF
    Regional suppliers of stabilizers, preservatives, and solubilizers that are compatible with peptide formulations.


Manufacturing and Contract Service Providers

Large-scale manufacturing of SENSIPAR involves not only raw material suppliers but also contract manufacturing organizations (CMOs) for final formulation, sterile filling, and packaging:

  • Catalent
    Expertise in sterile, injectable drug manufacturing, including lyophilization and fill-finish services, makes Catalent a preferred partner for bringing SENSIPAR to market.

  • Samsung Biologics and WuXi AppTec (also mentioned above) offer integrated manufacturing services, covering API synthesis, formulation development, and final packaging.


Regional Considerations in Supply Chain

North America and Europe
The US (through suppliers like WuXi and Samsung) and European suppliers such as Bachem and Boehringer Ingelheim are crucial for ensuring supply stability in developed markets. Regulatory familiarity and GMP compliance are critical factors for these regions.

Asia-Pacific
China and South Korea are prominent in peptide manufacturing. WuXi, Samsung, and other regional firms offer cost-effective, high-capacity options, often favored for their scalability and technological advancements.

Emerging Markets
Emerging economies increasingly rely on regional suppliers to reduce costs, though quality assurance remains paramount.


Strategic Implications for Stakeholders

  • Pharmaceutical Companies
    Engaging with diversified API suppliers mitigates risks associated with supply disruptions impacting SENSIPAR’s market availability.

  • Investors and Market Analysts
    Monitoring supplier relationships offers insights into potential production bottlenecks and opportunities for strategic partnerships or technological advances.

  • Healthcare Providers
    Ensuring consistent supply from reputable suppliers guarantees drug availability and patient outcomes.


Key Challenges and Considerations

  • Regulatory Compliance
    API suppliers must meet rigorous regulatory standards, and any deviations can delay or obstruct approval processes.

  • Supply Chain Resilience
    Geopolitical factors, export restrictions, and manufacturing disruptions necessitate diversified sourcing strategies.

  • Technological Capacity
    Peptide synthesis complexity demands high-end manufacturing infrastructure; suppliers’ technological readiness directly impacts quality.


Conclusion

SENSIPAR’s supply chain relies on a network of specialized API manufacturers, excipient providers, and contract manufacturers, primarily based in Europe, North America, and Asia-Pacific. Leading entities include Bachem, Boehringer Ingelheim, WuXi AppTec, and Samsung Biologics, each contributing to the drug’s high-quality production standards. A resilient, diversified supply chain involving these key players ensures the stable availability of SENSIPAR, aligning with regulatory standards and market demands.


Key Takeaways

  • The core API supplier for SENSIPAR is likely to be a leading peptide manufacturer with GMP-certified facilities, such as Bachem or WuXi AppTec.
  • Regional diversification mitigates risks, with prominent suppliers across Europe, North America, and Asia-Pacific.
  • Contract manufacturing organizations play a vital role in formulation, sterile filling, and packaging.
  • Maintaining regulatory compliance and technological capacity is critical for uninterrupted supply.
  • Stakeholders should closely monitor supplier relationships to anticipate supply chain disruptions or leverage new manufacturing capabilities.

FAQs

1. Who are the primary API suppliers for SENSIPAR?
Leading contenders include Bachem, WuXi AppTec, Boehringer Ingelheim, and Samsung Biologics, specializing in peptide synthesis and GMP-compliant manufacturing.

2. How does supplier diversification benefit SENSIPAR's supply chain?
It reduces dependency on a single source, minimizes risk of disruptions, and ensures consistent supply in different geographic markets.

3. Are there regional differences in SENSIPAR suppliers?
Yes. European and North American suppliers often comply with stricter regulations, while Asia-Pacific providers offer cost-effective, large-scale manufacturing options.

4. What role do excipient suppliers play in SENSIPAR production?
They provide necessary stabilizers and solvents ensuring drug stability, compatibility, and safe injection formulations.

5. How do regulatory standards influence supplier choices?
Suppliers must adhere to GMP and other regulatory standards; non-compliance can delay approvals and supply, emphasizing the importance of reputable, audited manufacturers.


Sources:
[1] Pharmaceutical regulatory guidelines and industry reports on peptide API manufacturing.
[2] Company websites and disclosures for Bachem, WuXi AppTec, Boehringer Ingelheim, Samsung Biologics.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.